PARISI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 143
NA - Nord America 116
EU - Europa 35
SA - Sud America 5
AF - Africa 3
Totale 302
Nazione #
US - Stati Uniti d'America 111
SG - Singapore 54
CN - Cina 49
IT - Italia 20
VN - Vietnam 19
HK - Hong Kong 6
IN - India 5
BD - Bangladesh 4
BR - Brasile 3
ES - Italia 3
GB - Regno Unito 3
CA - Canada 2
DE - Germania 2
ET - Etiopia 2
LT - Lituania 2
NL - Olanda 2
CL - Cile 1
CR - Costa Rica 1
FR - Francia 1
GT - Guatemala 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 302
Città #
Singapore 32
San Jose 25
Council Bluffs 22
Colorado Springs 18
Baltimore 7
Ashburn 6
Hanoi 6
Hong Kong 6
Ho Chi Minh City 5
Las Vegas 3
Los Angeles 3
New York 3
Addis Ababa 2
Barcelona 2
Beijing 2
Chennai 2
Florence 2
Frankfurt am Main 2
Jinan 2
Phủ Lý 2
Thái Nguyên 2
Almaty 1
Bengaluru 1
Brooklyn 1
Bảo Lộc 1
Chambersburg 1
Denver 1
Guatemala City 1
Hyderabad 1
Jaguaquara 1
Johannesburg 1
Kyiv 1
Liverpool 1
Ljubljana 1
Manchester 1
Meridian 1
Montreal 1
Mumbai 1
Orem 1
Panama City 1
Paso Canoas 1
Phoenix 1
Poplar 1
Punto Fijo 1
Quận Hai 1
Quận Phú Nhuận 1
Santa Clara 1
Santiago 1
Talence 1
Tampa 1
Tarlac City 1
Tashkent 1
Terrassa 1
Thái Bình 1
Tokyo 1
Toronto 1
Uberlândia 1
Vinhedo 1
Winter Garden 1
Totale 192
Nome #
Beyond Molecular Characterization: The Impact of Age-Adjusted Charlson Comorbidity Index in Glioblastoma Patients Treated with Radio or Radio-Chemotherapy 68
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy 39
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population 38
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population 37
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers 33
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab 32
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC‐D Index 32
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer 32
Totale 311
Categoria #
all - tutte 495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026311 0 0 0 0 22 48 90 40 38 66 7 0
Totale 311